Chronic hypnotic use: deadly risks, doubtful benefit

被引:95
|
作者
Kripke, DF [1 ]
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
hypnotics; epidemiology; mortality; hazard; triazolam; zolpidem; flurazepam;
D O I
10.1053/smrv.1999.0076
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the United States, roughly 2/3 of all hypnotic prescriptions go to chronic users, who have taken hypnotics for an average of 5 years or move. Two large prospective epidemiological studies have shown that reported hypnotic rise, especially use 30 times per month, is associated with an excess hazard of death. Indeed, use of hypnotics 30 times per month is associated with a similar mortality hazard to smoking 1-2 packs of cigarettes per day. Moreover, the hypnotic user's wish to improve daytime function is usually unfulfilled. The preponderance of evidence is that hypnotics impair performance, cognition and memory, increase the risk of automobile accidents and fails and promote unfavourable changes in personality. Due to tolerance, the sleep-promoting effects of hypnotics appear to be lost with chronic use. With long-term use, there is little controlled evidence that hypnotics produce benefits of any sort. More study of long-term hypnotic effects by public agencies is needed, but available evidence weighs strongly against long-term prescribing (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:5 / 20
页数:16
相关论文
共 50 条
  • [1] Improving evidence-based practice in the treatment of chronic insomnia:: a commentary for Sleep Medicine Reviews on "Chronic hypnotic use: deadly risks, doubtful benefits" (Daniel F.!Kripke)
    Reynolds, CF
    SLEEP MEDICINE REVIEWS, 2000, 4 (01) : 21 - 23
  • [2] DOUBTFUL BENEFIT
    LYNES, T
    NEW STATESMAN & SOCIETY, 1990, 3 (95): : 27 - 27
  • [3] Antipsychotics benefit doubtful
    不详
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2008, 12 (07) : 32 - 32
  • [4] EFFECTS OF CHRONIC HYPNOTIC USE
    KALES, A
    PRESTON, T
    TAN, TL
    SCHARF, M
    KALES, J
    PSYCHOPHYSIOLOGY, 1969, 6 (02) : 259 - &
  • [5] INABILITY TO DISCONTINUE CHRONIC HYPNOTIC USE
    Koshorek, G.
    Withrow, D.
    Roth, T.
    Roehrs, T.
    SLEEP, 2018, 41 : A158 - A158
  • [6] BZRA HYPNOTIC RECEPTOR SPECIFICITY AND ABILITY TO DISCONTINUE CHRONIC HYPNOTIC USE
    Roehrs, Timothy
    Koshorek, Gail
    Roth, Thomas
    SLEEP, 2023, 46 : A153 - A153
  • [7] CHRONIC HYPNOTIC USE: RISK OF REBOUND INSOMNIA
    Randall, S.
    Roehrs, T.
    Maan, R.
    Roth, T.
    SLEEP, 2009, 32 : A34 - A34
  • [8] Mood and Difficulty Discontinuing Chronic Hypnotic Use
    Roehrs, Timothy
    Sibai, Mohamad
    Tabor, Aisha
    Roth, Thomas
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [9] CHRONIC HYPNOTIC USE: ITS ABUSE LIABILITY
    Randall, S.
    Roehrs, T.
    Maan, R.
    Roth, T.
    SLEEP, 2009, 32 : A34 - A35
  • [10] ABILITY TO DISCONTINUE CHRONIC HYPNOTIC USE: AN UPDATE
    Roth, T.
    Koshorek, G.
    Verkler, J.
    Roehrs, T.
    SLEEP, 2020, 43 : A189 - A189